Bill Snyder

Vanderbilt scientists receive federal funding for two unconventional research projects

Figuring out how biological clocks evolved and extracting clues to environmental factors that cause cancer from electronic medical records: These are the goals of two projects that have been funded by a National Institutes of Health (NIH) program.

Vanderbilt’s Emergency Department to Test All Adult Patients for HIV

This month, Vanderbilt University Medical Center will begin routine and rapid HIV testing of all adults seen in the Emergency Department unless they “opt out” of the procedure.

Vanderbilt awarded $4.4 million by the Michael J. Fox Foundation; Goal is to develop new class of Parkinson’s disease drugs

A drug discovery team at Vanderbilt University Medical Center led by Jeffrey Conn has been awarded a $4.4 million “LEAPS” grant by the Michael J. Fox Foundation for Parkinson’s Research to jump-start development of a new class of Parkinson’s diseasedrugs.

Aeras and Vanderbilt University Announce License Deal for New TB Vaccine

The Aeras Global TB Vaccine Foundation of Bethesda, Md., and Vanderbilt University of Nashville, Tenn., announced that the two organizations had executed an exclusive license for a tuberculosis vaccine.

Vanderbilt develops new tuberculosis vaccine

A Vanderbilt-led team of researchers has developed a new vaccine technology that may prevent the spread of tuberculosis, which kills more than two million people worldwide each year.

Vanderbilt to participate in worldwide test of HIV vaccine

Vanderbilt University Medical Center is participating in worldwide tests of a potential vaccine that can stimulate important immune responses against the virus that causes AIDS.

1 113 114 115